LCAR-BCX cells / Legend Biotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LCAR-BCX cells / Legend Biotech
NCT04601935: A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma

Active, not recruiting
1
34
RoW
LCAR-BCX cells product
Weijun Fu, Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
01/23
10/24

Download Options